Glibenclamide treatment blocks metabolic dysfunctions and improves vagal activity in monosodium glutamate-obese male rats.
Franco CCS, Prates KV, Previate C, Moraes AMP, Matiusso CCI, Miranda RA, de Oliveira JC, Tófolo LP, Martins IP, Barella LF, Ribeiro TA, Malta A, Pavanello A, Francisco FA, Gomes RM, Alves VS, Moreira VM, Rigo KP, Almeida DL, de Sant Anna JR, Prado MAAC, Mathias PCF.
Franco CCS, et al. Among authors: tofolo lp.
Endocrine. 2017 May;56(2):346-356. doi: 10.1007/s12020-017-1263-z. Epub 2017 Feb 23.
Endocrine. 2017.
PMID: 28233096